Healthcare Insights by KYBORA

Healthcare Insights by KYBORA

KYBORA is a global advisory firm and investment bank whose mission is to guide transformative healthcare companies to enduring success globally

Episodes

  1. Jul 7

    From Auditor to Chairman: A Finance Journey Through Biotech

    Our Founder & CEO, Alan Vanderborght, talks with veteran biotech CFO and Chairman of the Board at Egetis Therapeutics, Mats Blom, about a finance-first career across Europe and the US, what AI could mean for drug development, and the personal pull of rare disease - where success is measured in the handful of faces you can actually see.

  2. Jul 1

    The Innovator’s Mindset: Evolution in Biotech

    In this episode, our Founder & CEO, Alan Vanderborght, sits down with Carter King, EVP Business Development at Protagonist Therapeutics, for a candid conversation about his journey to the frontier of drug development, the science of turning injectables therapies into pills, and the deal-making wisdom and resilience behind a 25-year carreer in biotech.

  3. May 18

    The Hearing-Dementia Link: Leading a Scientific Revolution

    In this episode, our Founder & CEO, Alan Vanderborght, sits down with Celia Beline, CEO of Cilcare, for a conversation about pioneering the field of hearing health, the strategic development of disease-modifying drugs for "hidden" hearing loss, and the critical discovery that hearing is a primary modifiable risk factor for dementia.

  4. Mar 17

    Leading a Global Giant: AI Innovation & Microbiome Science

    In this episode, Alan sits down with Nicolas Coudurier, CEO of Biocodex, for a conversation on leading a family-owned global giant, the strategic integration of AI, the evolution of microbiome science and its connection to the brain. Nicolas shares insights from his career journey, including what it takes to drive continuous change while successfully scaling across several subsidiaries.

  5. Jan 9

    Bridging Science and Capital: Strategic Leadership in Biopharma

    In this episode, Alan sits down with David H. Crean,Chief Business Officer at MediciNova, for a conversation on leadership,strategy, and navigating complexity in the biopharma industry. David shares insights from his career journey and whatit takes to build value in late-stage biotech. They explore decision-making inhigh-risk environments, the role of strategic partnerships, and the challengesof advancing innovation in neuroscience today.

    Bridging Science and Capital: Strategic Leadership in Biopharma

  6. 09/23/2025

    CEO Insights: Immunotherapy Innovation, AI Challenges & Clinical Trial Observations

    In this episode of Healthcare Insights by KYBORA, our CEO & Founder, Alan Vanderborght, sits down with David Apelian, CEO at Theolytics, for a conversation about the industry. Together, they explore immunotherapy, AI, and the innerworkings of clinical trials.

    CEO Insights: Immunotherapy Innovation, AI Challenges & Clinical Trial Observations

  7. 09/11/2025

    The AI Effect on the Biopharma Market

    In this episode, our CEO Alan Vanderborght sits down with William Compton, SVP, Digital Enabling Functions and Colleague Services at Pfizer. Together, they discuss the effects of AI on the industry and what the future may look like.

    The AI Effect on the Biopharma Market

  8. 07/29/2025

    Global Biopharma Today: Funding Trends and Future Outlook

    In this episode, KYBORA's CEO, Alan Vanderborght, sits down with Richard Davies, Deputy Chairman of the Board at Alvotech, for a conversation about Richard's extensive industry experience, the current state of Biopharma, funding hurdles and the future of the industry.

    Global Biopharma Today: Funding Trends and Future Outlook

  9. 06/29/2025

    ALS Innovation: Where Science is Leading Us

    KYBORA's CEO, Alan Vanderborght, sits down with Raya Therapeutic Founder, Anjan Aralihalli, for an inspiring conversation about Anjan's background, ALS breakthroughs and how Raya Therapeutic came to be.

    ALS Innovation: Where Science is Leading Us

  10. 06/04/2025

    Inside China's R&D powerhouse: Strategic Insights for Pharma leaders

    Join us for our third episode! KYBORA's CEO Alan Vanderborght invites Dr. Weiyong Sun, Chief Business Officer at Hansoh Bio, for an insightful conversation about current issues in the industry, including the impact of China's growing R&D capabilities on the US pharmaceutical business.

    Inside China's R&D powerhouse: Strategic Insights for Pharma leaders

  11. 05/08/2025

    Biopharma Today: Tariff Pressures and Industry Transformation

    In this episode, KYBORA's CEO Alan Vanderborght, and guest Carlo De Notaristefani, President at CDN Advising, discuss supply chain management, tariff pressures and the evolution of the Biopharma industry.

    Biopharma Today: Tariff Pressures and Industry Transformation

  12. 03/12/2025

    The Science and Business Behind Healthcare

    In the first episode of our podcast, guest John Gregg and host Alan Vanderborght discuss John's time and extensive experience in the industry, as well as various scientific innovations and the future of the healthcare industry.

    The Science and Business Behind Healthcare
  • 12 Episodes

About

KYBORA is a global advisory firm and investment bank whose mission is to guide transformative healthcare companies to enduring success globally

Information

  • Creator
    Healthcare Insights by KYBORA
  • Years Active
    2025 - 2026
  • Episodes
    12
  • Rating
    Clean
  • Copyright
    © Healthcare Insights by KYBORA
  • Show Website
    Healthcare Insights by KYBORA